Category: FDA & Product Rules

FDA & Product Rules

DEA Resets Its 7-OH Kratom Threshold as States Split Over Leaf Sales

DEA filed a notice on October 9 that would schedule 7-OH and mitragynine pseudoindoxyl above 1 milligram per gram or a set ratio to mitragynine, replacing its July 0.050 percent proposal, while MGM-15 and MGM-16 stay in Schedule I and Tennessee, Massachusetts, Rhode Island, and Pennsylvania draw different state lines for kratom sellers.

E-commerce 4 Internet Marketers Editorial
FDA & Product Rules

FDA Peptide Warning Letters Show Research Use Only Labels Did Not Shield Online Vendors

FDA's August 24, 2026 warning letters to Peak Performance Peptides, Royal Peptides, NuScience Peptides, Peptide Partners, and Tex Peptides set aside research use only disclaimers and list the product pages, study summaries, blog posts, calculators, and bacteriostatic water that FDA treated as evidence of intended human use.

E-commerce 4 Internet Marketers Editorial